Nov 2 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2018 Sep 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.48 32.41 63.00
(-6.0 pct) (+0.3 pct) (-2.4 pct)
Operating 2.07 2.39 4.30
(-13.5 pct) (-24.0 pct) (-11.0 pct)
Recurring 1.91 2.53 4.00
(-24.5 pct) (-17.8 pct) (-21.4 pct)
Net 2.28 2.13 3.60
(+7.2 pct) (+6.1 pct) (-13.4 pct)
EPS 45.40 yen 40.70 yen 71.75 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T